Skip to content
CFPS Research Archives

Wolverine Blend (BPC-157 + TB-500)

Preclinical only Healing & Recovery 3 sources

The 'Wolverine Blend' is a popular research combination of two well-known healing peptides: BPC-157 and TB-500 (Thymosin Beta-4). Research suggests that BPC-157 promotes angiogenesis and gastrointestinal healing, while TB-500 upregulates actin, facilitating cell migration and tissue repair. Together, they are studied for their synergistic potential in accelerating recovery from muscle, tendon, and ligament injuries.

01Dosing reference

Amount
BPC-157: 250-500 mcg/day; TB-500: 2-5 mg/week
Frequency
BPC-157 daily; TB-500 split into 2 injections per week
Cycle
4-6 weeks on, followed by 4 weeks off
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Angiogenesis and Actin Upregulation

BPC-157 stimulates the formation of new blood vessels (angiogenesis) via VEGF pathways, while TB-500 binds to cellular actin to promote cell migration.

02

Accelerated Tissue Repair

The combined action increases blood flow to damaged areas and provides the cellular building blocks needed for rapid tissue regeneration.

03

Synergistic Healing

Researchers hypothesize that combining enhanced nutrient delivery (BPC-157) with improved cellular mobility (TB-500) leads to faster recovery of tendons, ligaments, and muscles.

03Human evidence

Lack of formal clinical trials for the blend

While individual components like Thymosin Beta-4 have seen limited human trials for specific conditions, the BPC-157/TB-500 combination lacks formal human clinical trials and is primarily studied in animal models or used anecdotally.

Anecdotal reports of accelerated recovery

Observational and anecdotal reports from sports medicine contexts suggest rapid recovery from musculoskeletal injuries, though these lack placebo-controlled validation.

04Preclinical evidence

Tendon and ligament healing

In rat models, BPC-157 has been shown to significantly accelerate the healing of transected Achilles tendons and medial collateral ligaments.

Muscle regeneration and cardioprotection

Animal studies demonstrate that TB-500 promotes skeletal muscle regeneration and improves survival of heart tissue following ischemia.

05What is known vs. unknown

Reasonably established
  • Combines BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4 fragment).
  • BPC-157 primarily drives angiogenesis and protects the gastrointestinal tract.
  • TB-500 plays a key role in actin sequestration, aiding in cell migration and tissue repair.
  • Often researched for severe musculoskeletal injuries, including tendon tears and muscle strains.
Unknowns & limits
  • Lack of standardized human clinical trials evaluating the safety and efficacy of the combined blend.
  • Long-term effects of sustained angiogenesis and actin upregulation are not fully understood.
  • Optimal dosing ratios between BPC-157 and TB-500 remain speculative and based on anecdotal protocols.

06Safety & regulatory context

Regulatory statusNeither BPC-157 nor TB-500 is approved by the FDA for human use, and both are banned by the World Anti-Doping Agency (WADA) for use in competitive sports. The FDA has recently categorized BPC-157 as a substance that presents significant safety risks, leading to its removal from compounding pharmacy bulk lists. Potential side effects of the blend are not well-documented in clinical literature but may include injection site reactions, fatigue, or theoretical risks associated with unregulated angiogenesis.

07Compared with BPC-157 (Standalone)

Wolverine Blend (BPC-157 + TB-500) vs. BPC-157 (Standalone)
Key difference
The blend adds TB-500, which provides systemic cellular migration benefits via actin binding, whereas BPC-157 alone is more localized and focused on angiogenesis and gut health.
When researchers discuss each
BPC-157 is often discussed for localized joint/tendon repair or gut issues, while the Wolverine Blend is discussed for systemic, severe, or multi-site musculoskeletal trauma requiring maximum regenerative support.

08Glossary

Angiogenesis
The physiological process through which new blood vessels form from pre-existing vessels.
Actin
A protein that forms the contractile filaments of muscle cells and is involved in motion and cellular structure.
Synergy
The interaction of two or more substances to produce a combined effect greater than the sum of their separate effects.

09Knowledge check

Q1What is the primary mechanism of action for the TB-500 component in the Wolverine Blend?
Q2Why is the combination of BPC-157 and TB-500 often referred to as synergistic in research?
Q3Which statement best reflects the current human evidence for the Wolverine Blend as described in the dossier?
Q4According to the dossier, how is the Wolverine Blend discussed differently from BPC-157 used alone?
Q5Which regulatory and safety statement matches the dossier's description of BPC-157 and TB-500?

10Sources

More in Healing & Recovery

See all

BPC-157

Healing & Recovery
Early human

BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.

250-500 mcg

TB-500 (Thymosin Beta-4)

Healing & Recovery
Early human

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.

2.0 - 2.5 mg per injection

KPV

Healing & Recovery
Early human

KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.

200-500 mcg/day
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.